Skip to Main Content

Author Details

Jane Bayani
Ontario Institute for Cancer Research
1995
97
37
PMIDPaper TitleJournal TitlePublished Year
37081426The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).BMC Cancer2023
37965470Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence.Front Oncol2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
35027623Upregulation of IFNÉ£-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma.Sci Rep2022
35494042Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial Protocol.Front Oncol2022
35526835Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer.J Mol Diagn2022
32471889Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study.J Clin Pathol2021
34597339Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours.PLoS One2021
34238931Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.NPJ Breast Cancer2021
34312396Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.NPJ Breast Cancer2021
33022560Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?Pathol Res Pract2020
32881987Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.PLoS One2020
30143750An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.Mod Pathol2019
35100692Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers.JCO Precis Oncol2019
29092024Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.Ann Oncol2018
30029633Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival.BMC Cancer2018
29917140Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial.J Natl Cancer Inst2018
28649643Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine.NPJ Breast Cancer2017
27130929Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.J Natl Cancer Inst2016
27429011EMT in Breast Carcinoma-A Review.J Clin Med2016
25561528Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity.Proc Natl Acad Sci U S A2015
23136250Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.Clin Chem2013
24294176Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.Radiol Oncol2013
23623180Analysis of genomic abnormalities in tumors: a review of available methods for Illumina two-color SNP genotyping and evaluation of performance.Cancer Genet2013
23765253Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.Thromb Haemost2013
22505521Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients.Biol Chem2012
22926558Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma.Cancer Res2012
20800559Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.Mol Oncol2011
22047144The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Clin Chem Lab Med2011
21508638Integrated cytogenetic and high-resolution array CGH analysis of genomic alterations associated with MYCN amplification.Cytogenet Genome Res2011
20564316Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.Prostate2010
19497285Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.Cell Stem Cell2009
18295659Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.Cancer Genet Cytogenet2008
19383346Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer.Mol Oncol2008
18813350Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer.Neoplasia2008
18931480Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.Cytogenet Genome Res2008
18519696ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.Cancer Res2008
16814562Stem cell enrichment approaches.Semin Cancer Biol2007
17981215Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization.Cancer Genet Cytogenet2007
17603634Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.Neoplasia2007
17584912Microdeletion and concurrent translocation associated with a complex TMPRSS2:ERG prostate cancer gene fusion.Genes Chromosomes Cancer2007
17845729Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation.Cancer Cell Int2007
17268171Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer.Cytogenet Genome Res2007
17287077Application and interpretation of FISH in biomarker studies.Cancer Lett2007
17099872Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.Genes Chromosomes Cancer2007
17028864Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome.Hum Genet2007
17126026Genomic mechanisms and measurement of structural and numerical instability in cancer cells.Semin Cancer Biol2007
16897100The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma.Chromosoma2006
17077140Expression of TEL-JAK2 in primary human hematopoietic cells drives erythropoietin-independent erythropoiesis and induces myelofibrosis in vivo.Proc Natl Acad Sci U S A2006
16820092Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.Neoplasia2006
  • 1 - 50 of 97

Recommended Authors

Cherry Have
University Health Network
Career Start Year 2007
Number of shared co-authors 10
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 0
Darawalee Wangsa
Center for Cancer Research, National Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
Jill M Hagenkord
Color Genomics Inc.
Career Start Year 2004
Number of shared co-authors 0
Jordi Camps
Universitat Autonoma de Barcelona
Career Start Year 2003
Number of shared co-authors 0
Maryou B Lambros
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 5
Marilyn M Li
Children's Hospital of Philadelphia
Career Start Year 2000
Number of shared co-authors 5
Yi-Jue Zhao
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 1
Karoly Szuhai
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 3
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Danny Wangsa
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 2
Michael Baudis
University of Zurich
Career Start Year 1995
Number of shared co-authors 2
Alexei Protopopov
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Doris Steinemann
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 8
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 1
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 3
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 8
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 8
Nallasivam Palanisamy
Vattikuti Urology Institute
Career Start Year 1990
Number of shared co-authors 2
Thomas Ried
Center for Cancer Research, National Cancer Institute
Career Start Year 1989
Number of shared co-authors 3
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 21
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 3
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Career Start Year 1987
Number of shared co-authors 15
Peter Lichter
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 13
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 3
Ola Myklebost
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1983
Number of shared co-authors 1
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 12
Joe W Gray
Oregon Health and Science University
Career Start Year 1974
Number of shared co-authors 5
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 9

Collaborators

Jeremy A Squire
University of Sao Paulo
Co-authored papers 72
John M S Bartlett
University of Edinburgh
Co-authored papers 15
Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 7
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Co-authored papers 6
Tammy Piper
University of Edinburgh
Co-authored papers 5
Paul C Boutros
University of California los angeles
Co-authored papers 5
James T Rutka
Hospital for Sick Children
Co-authored papers 4
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 4
Cheryl Crozier
Ontario Institute for Cancer Research
Co-authored papers 4
Caroline Seynaeve
Erasmus Medical Center
Co-authored papers 4
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Co-authored papers 4
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 4
Elizabeth N Kornaga
Tom Baker Cancer Centre
Co-authored papers 4
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 4
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 4
Christos Markopoulos
National and Kapodistrian University of Athens
Co-authored papers 4
Silvia Regina Caminada de Toledo
Pediatric Oncology Institute (IOP/GRAACC), Federal University of Sao Paulo
Co-authored papers 3
Ekaterina Olkhov-Mitsel
University of Toronto
Co-authored papers 3
Elizabeth Mallon
Queen Elizabeth University Hospital
Co-authored papers 3
Poul H Sorensen
British Columbia Cancer Research Centre
Co-authored papers 3
Stanley K Liu
Odette Cancer Centre, University of Toronto
Co-authored papers 3
Janet A Dunn
Warwick Clinical Trials Unit, University of Warwick
Co-authored papers 3
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 3
Glenn Bauman
Western University and London Regional Cancer Program
Co-authored papers 3
Robert C Stein
12 University College London Hospitals National Health Service Foundation Trust
Co-authored papers 3
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Co-authored papers 3
Michelle R Downes
University of Toronto
Co-authored papers 3
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Co-authored papers 3
Ian D Clarke
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Co-authored papers 3
Kim Benstead
Gloucestershire Hospitals NHS Foundation Trust
Co-authored papers 2
Release 1.2